Key insights
- An analyst warns against investing in POET Technologies despite its promising 'Optical Interposer' technology. The company has a history of zero revenue, questionable financial practices like shelf registrations for share dilution, and a failed partnership due to CFO misconduct. The analyst draws parallels to Rockley Photonics' bankruptcy, suggesting POET's $50 million order is misleading and paid in stock options, making it a risky investment.
TL;DR: Don't get blinded by the hype on this one. The tech sounds great, but the business is a massive red flag. They haven't made real money in ten years, and the CFO recently tanked their only legitimate partnership by leaking secrets in an interview. That new "$50 million order" headline is smoke and mirrors it's actually paid in stock options and tied to a startup with broken tech.
Look, I spent a good chunk of my Sunday looking over the charts and watching this stock take an absolute beating on Friday. I wanted to write this up because I see a lot of regular guys getting sucked into the hype right now, thinking this is a safe, easy bet for the AI boom. On the surface, the pitch for POET Technologies sounds amazing.
We all know data centers are running incredibly hot and old copper wire is hitting a physical wall. POET says their "Optical Interposer" fixes the bottleneck by putting electronics and light on one single chip. It sounds like a home run.
But there is a massive difference between a cool engineering project in a lab and a business that actually makes money. If you look at the track record for this specific corner of the tech industry, it is a graveyard of companies that promised a revolution and left retail holding the bag. Look at Rockley Photonics. They raised hundreds of millions of dollars on the exact same dream and went completely bankrupt. POET has been around for ten years now and their actual revenue is basically zero. It is just enough to pay their accounting fees to file compliance paperwork. The science might be neat, but they have not proven they can actually manufacture a single thing at scale.
Back on January 22nd, they filed an automatic shelf registration with the SEC. If you don't know what that is, it is basically a pre-approved hall pass to print and dump new shares on the market whenever management wants cash. They have been running this exact same playbook since late 2024, and keeping that in mind explains exactly why the stock collapsed at the end of the week.
The multi-million dollar misstep
A company can have a great concept, but human beings still have to run it, and people have a bad habit of talking too much. Back in late April, POET got a real milestone design win with Celestial AI. It was exactly what they needed to build some commercial credibility after years of looking like a science project. Investors started buying in and the stock took off.
Then the CFO goes on a public broadcast interview. Instead of keeping the details quiet, he starts openly talking about specific timelines and delivery schedules, completely violating a strict, legally binding NDA. The fallout was instant. Marvell Technology, who had just bought Celestial AI, cancelled the whole partnership on the spot and sued them. That case goes to court in mid-June.
Nearly half the company's entire value vanished in a single afternoon, all because an executive couldn't follow basic corporate discipline and keep his mouth shut.
The reality behind the 50 million dollar order
That brings us to the sudden "miracle" order that pumped the stock back up this month. On May 14th, POET announced a massive 50 million dollar purchase order from a startup called Lumilens. If you look at the timeline, there is a serious red flag that’s worth investigating.
Just seven weeks before signing that deal, Lumilens had acquired a struggling Singaporean firm called Rain Tree Photonics. Rain Tree spent a decade failing to launch, making less than 800k in total revenue over three years while burning through its assets. Their technology suffered from fundamental manufacturing flaws, specifically severe chip warping and alignment issues, that kept it from ever being mass-produced.
Why would a stable, well-funded business rush to place a 50 million dollar order with a supplier that just self-sabotaged and lost half its value two months ago?
They didn't care about the tech, Lumilens was a willing partner playing a completely different financial game. My dad always told me you can't cheat an honest man, but a guy who thinks everyone else is a sucker…he’s fair game.
The short report that hit on Friday morning exposed the whole thing. POET didn't actually sell them physical hardware. They handed Lumilens a massive equity sweetener instead, specifically options to buy more than 22 million shares of POET stock at a cheap price of 8.25 per share over the next nine years. Crucially, 10% of those options could be cashed out instantly.
Regular investors just saw the flash headline about a "50 million dollar order" and rushed in, driving the stock to 20.57 by Thursday night. Meanwhile, without shipping a single piece of hardware, Lumilens was instantly handed millions of dollars in free paper wealth they could flip right away.
The dilution problem and Monday's outlook
If you want to see what is actually happening to your money, look at the share printing press. Look at the volume of shares they have printed over the last several months just to keep the lights on. In November 2024 it was 25 million. October 2025 was 75 million, followed immediately by another 150 million. January 2026 was 150 million. Then this May they dropped a massive 400 million dollar share offering.
That is roughly 800 million dollars drained from the public market in less than eight months. Management has established a clear pattern here, they wait for an AI-related headline to pump the stock price, and then they immediately issue a massive wave of new shares, diluting the value for everyone already holding.
On Friday morning, right at the peak of the hype from the Lumilens headline, POET pulled the trigger on that pre-approved permit and announced their newest 400 million dollar share print at 21.00 a share. Regular investors got completely blindsided, the short report dropped at the same time, panic set in, and the stock cratered to 15.97 by Friday's close.
The most concerning part is that across four consecutive massive funding rounds, not a single institutional buyer has been publicly named. Every single deal has been non-brokered, handled quietly through a middleman called Titan Partners Group. A single anonymous entity keeps appearing on their regulatory filings, holding exactly 9.99% of the stock, which is the precise legal limit below which you don't have to publicly disclose your identity.
This sets up a very volatile situation for tomorrow morning. The unknown institutional investor who agreed to take Friday’s deal at 21.00 a share is already sitting on a 24% loss before trading even starts. Because that deal doesn't officially close until Monday morning, that buyer is going to be highly motivated to defend their entry price. If you see a sudden burst of heavy buying support in the first 30 minutes of trading, do not make the mistake of thinking the market suddenly loves POET’s technology. That is simply a massive institutional position frantically trying to prop up the price so they can minimize their losses and find a way out.
Friday’s aggressive sell-off tells you everything you need to know. Professional funds don't dump massive amounts of stock because they're being emotional, they dump it because the business fundamentals don't live up to the marketing. There is no scaled manufacturing happening here and there are no active factories. The entire valuation rests on the blind hope that a company with a long history of missing deadlines will suddenly deliver a flawless product on a perfect schedule.
Management handled a terrible situation remarkably well for themselves. They used a well-timed contract headline to erase a massive corporate blunder, pumped the stock back up, and locked in 400 million in fresh capital right at the top. But they left behind too many obvious warning signs between the executive who leaked his own deal, a partner built on broken technology, and a funding structure that continuously punishes everyday shareholders.
I don’t know what’s gonna happen tomorrow, this is not financial advice and I sure as hell don’t intend to be qualified to provide such financial advice. But if you read this far, check my homework, if you find something that invalidates what I’ve said drop a comment and help me figure out why this isn’t fishy.